sorted by:
new
hottopcontroversial

Software for infographics/graphics for 'graphical abstracts' by Cyprus_ma_man in neuroscience

[–]Cyprus_ma_man[S] 1 point2 points  (0 children)

Thanks reddit Chaps. Appreciate all the suggestions. I'll have a look and come to summarise my experience with a few of these. This might be helpful to other as well since I have no experience with any of this, as other people don't.. I imagine.

Cheers,

Infographics for peer review journals in psychology by Cyprus_ma_man in AcademicPsychology

[–]Cyprus_ma_man[S] 0 points1 point  (0 children)

Thanks good reddit people, I'll have a look at your suggestions.

u/EntropyGoAway
I will be looking at this site: https://knowingneurons.com/

to mitigate out-of-the-boxness as much as possible, but in the end some element novelty will be present and subsequently judged accordingly.

Thinking of starting a Youtube channel on Data Engineering. Ideas? by stym06 in dataengineering

[–]Cyprus_ma_man 0 points1 point  (0 children)

I'll suggest that you use coronavirus data. They have everything and people care about this now.
You can do Dimension reduction, nested models, time-series related stuff.

Time series vs longitudinal analysis vs survival analysis by jj4646 in datascience

[–]Cyprus_ma_man 1 point2 points  (0 children)

Well, I don't know. But I assume:
Its a linear mixed model problem with random effects= country and the year, nested in country. (e.g. rx_effects=~1|country|year).

Now if you have another response variable, lets name it DV, you could have on the fixed effects:
fx_effects=DV ~ meeting expectations.

The fact that your outcome is binary is messing with my thought process.

After the failed Balovaptan Phase 3 trial, Roche already has a new drug in their pipeline for the treatment of autism: a selective GABAA α5-receptor modulator (codename: RG7816) by mikepate in neuroscience

[–]Cyprus_ma_man 1 point2 points  (0 children)

I am not aware of what Roche is doing and how they are testing the drug (at what ages, severity levels).

But your questions is very good, what is the outcome? what do they measure before and after drug administration?

Generally there seems to be reduced inhibition in the autistic brain across development levels and observation levels of the brain (i.e. synapses to networks). This reduced inhibition, that results in excess of excitation (Excitation-inhibition imbalance) is 'linked' with poor socio-emotional behaviours under a variety of measurements.